Biotech, Food, Drug

The food we eat and the medicine we put into our bodies are highly regulated by a variety of government agencies. In the United States by the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) regulate the processes by which food makes its way to the grocery store and medicine is approved for consumer use.  As the science grows more complex behind the pharmaceutical and food industry, interpretation of the regulations in place is becoming more nuanced.  Overseas, these industries are regulated by a variety of agencies; for example, the Minister of Agriculture in Canada, Centre for Food Safety in Hong Kong, and the Committee of Environmental, Public Health and Food Safety (EU), are among the many governing-bodies which regulate biotechnology, food, and drugs throughout the world.

The National Law Review is your free online resource to agency news, emerging topics in food and drug, and the latest in biotechnology updates. From nanotechnologies being used in research, to regulations of imported foods coming into the US from overseas or the development of medical devices and drugs, readers can find expert legal analysis of the developments in the industry, as well as reports on changes within the agencies that regulate these industries. The National Law Review also covers topics related to licensing, Food Safety and Inspection Services (FSIS), food and beverage regulation in the US and worldwide, nutrition labeling, and country of origin labeling guidelines.

With recent legislation being passed throughout the US in relation to marijuana use, both for recreational and medicinal purposes, readers will also find up-to-date information, litigation, and news coming from this area of interest as well. Regulations in California for labeling and proper sales of marijuana, to use in different states, or internationally, as well as rules for promoting and advertising marijuana are also covered on the site. Additionally, the development and changing landscape of tobacco use to include vaping, and how e-cigarettes and vaping are regulated, is also covered by NLR authors.

Readers who are interested in food safety, inspection, imports into the US, and regulations, these topics are covered regularly on The National Law Review as well. New legislation from the FDA, USDA, Department of Agriculture, and international bodies, are covered on the site. If you are looking for details on new nutrition-labeling regulations or health risks of consuming certain imported foods, you will find these topics, and many more, on The National Law Review.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Sort descending Organization
May
20
2020
Antitrust Division Gives Thumbs Up to Pork Farmers’ Collaboration on Hog Euthanasia Mintz
Mar
23
2020
Antitrust Enforcers Target Coronavirus-related Violations Proskauer Rose LLP
May
11
2022
Antitrust Enforcers’ First “Listening Forum” On Merger Reform Highlights Ongoing Concerns in the Food and Agriculture Industry Polsinelli PC
Mar
5
2020
Antitrust Liability Risk When Listing Patents in Orange Book McDermott Will & Emery
Oct
10
2019
Antitrust Surprises from DOJ during the Trump Administration – Predicting the Consequences Foley & Lardner LLP
May
19
2016
Antitrust: Third Circuit Provides Guidance on Loyalty Discounts ArentFox Schiff LLP
Jul
31
2023
APHIS 2022 Impact Report Includes Summary of Biotechnology Activities Bergeson & Campbell, P.C.
Mar
23
2023
APHIS Accepting Public Comments on Draft Guide for Submitting Permit Applications for Microorganisms Developed using Genetic Engineering Bergeson & Campbell, P.C.
Aug
31
2021
APHIS Announces Draft Regulatory Status Review Guide Available for Public Comment Bergeson & Campbell, P.C.
Oct
7
2022
APHIS BRS Will Hold Annual Stakeholder Meeting on December 8, 2022 Bergeson & Campbell, P.C.
Dec
21
2023
APHIS Extends Comment Period on Proposed Exemptions for Genetically Modified Plants Keller and Heckman LLP
Oct
11
2022
APHIS Issues RSR Responses under Revised Biotechnology Regulations Bergeson & Campbell, P.C.
Oct
24
2022
APHIS Issues RSR Responses under Revised Biotechnology Regulations for Modified Corn and Potato Plants Bergeson & Campbell, P.C.
Nov
16
2023
APHIS Proposes Five Additional Exemptions for Plants Modified or Produced Through Genetic Engineering Bergeson & Campbell, P.C.
Jun
8
2019
APHIS Proposes Revised Regulatory Framework Regarding the Movement of Certain Genetically Engineered Organisms Bergeson & Campbell, P.C.
May
3
2023
APHIS Releases New Strategic Plan for 2023-2027, Includes Biotechnology Objectives Bergeson & Campbell, P.C.
Oct
20
2023
APHIS Releases Revised Draft and Response to Comments on Guide for Submitting Permit Applications for Microorganisms Developed Using Genetic Engineering Bergeson & Campbell, P.C.
Oct
19
2023
APHIS Releases Revised Guidance for Genetically Engineered Microorganism Applications Keller and Heckman LLP
Jan
3
2024
APHIS Reopens Comment Period on Proposed Additional Exemptions for Plants Modified or Produced Through Genetic Engineering Bergeson & Campbell, P.C.
Apr
1
2024
APHIS Seeks Comment on Draft EIS for Deregulation of Maize Developed Using Genetic Engineering Bergeson & Campbell, P.C.
Apr
12
2023
APHIS Seeks Comment on Draft Environmental Documents for Deregulation of Corn Developed Using Genetic Engineering Bergeson & Campbell, P.C.
Mar
3
2015
APHIS Withdraws 2008 Proposal to Amend Regulation of GE Organisms: Animal and Plant Health Inspection Service Beveridge & Diamond PC
Jul
24
2018
APHIS/USDA Prepare to Revise Regulations Pertinent to Genetically Engineered Organisms Bergeson & Campbell, P.C.
Sep
15
2016
Apotex Biosimilar Cleared Of Infringement But Pre-Marketing Notice Still Required Foley & Lardner LLP
Apr
9
2015
Apotex Has Standing Despite Benicar Patent Disclaimer Foley & Lardner LLP
May
21
2015
Apotex Petitions Supreme Court to Review Therasense Standards Schwegman, Lundberg & Woessner, P.A.
Sep
1
2016
Apotex v Wyeth Explores Structural Obviousness Schwegman, Lundberg & Woessner, P.A.
Jul
6
2016
Apotex—Biosimilars Must Provide 180-Day Marketing Notice After FDA Approval Morgan, Lewis & Bockius LLP
Oct
26
2017
Appeal of Discovery Order in BPCIA Patent Infringement Case Dismissed for Lack of Jurisdiction and Writ of Mandamus for Compelling Discovery Denied Hunton Andrews Kurth
Apr
20
2020
Appellant Plaintiffs in Multidistrict Litigation Argue a Jury Should Decide if the Claim “100% Grated Parmesan” is Deceptive When Cellulose is a Listed Ingredient Keller and Heckman LLP
Sep
24
2012
Appellate Court Ruling Permits Continued NIH Funding of Embryonic Stem Cell Research Schwegman, Lundberg & Woessner, P.A.
Jul
28
2021
Applying for a License to Cultivate Medical Cannabis in Alabama Bradley Arant Boult Cummings LLP
Jul
28
2021
Applying for a License to Dispense Medical Cannabis in Alabama Bradley Arant Boult Cummings LLP
Jul
22
2021
Applying for a License to Process Medical Cannabis in Alabama Bradley Arant Boult Cummings LLP
Dec
22
2018
Appropriations Continuing Resolution Passed by the Senate on December 19, 2018, Extends PRIA through February 8, 2019 Bergeson & Campbell, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins